{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:51:09Z","timestamp":1777398669913,"version":"3.51.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Multiple sclerosis (MS) is a neurodegenerative condition that results in demyelination of the central nervous system. Visual impairment, retinal nerve fiber layer thinning, and impaired electrical function in retinal ganglion cells are seen throughout disease progression and serve as useful markers for treatment success. Current research examining the effects of ketogenic diet (KD) as cotherapy show promising anti-inflammatory properties, but research remains limited by differences in experimental set-up and KD composition. The purpose of our study was to use functional and structural biomarkers to determine the neuroprotective effects of a KD composed of long-chain, saturated fatty acids and how the timing of its implementation impacts these biomarkers in an experimental autoimmune encephalomyelitis (EAE) model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>EAE was induced in 80 female C57BL\/6J mice by immunization with MOG35-55 and randomly assigned to stay on the standard diet or to start the KD at one of three time points (preconditioned, prophylactic, or late). Motor-sensory scores, visual acuity, OCT, electrophysiology, and histopathology were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In general, our results show that a KD with long-chain, saturated fatty acids did not significantly improve visual outcomes, and that early implementation of the diet modestly exacerbated motor-sensory and visual acuity deficits despite not impacting optic nerve axonal damage, retinal ganglion cell loss, or psychomotor measurements of visual system function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>We propose that the anti-inflammatory neuroprotective benefits of a KD are limited when saturated, long-chain fatty acids are used, and that chain length and fat saturation should be taken into account when utilizing KD as a treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1587760","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:14:15Z","timestamp":1747887255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A high-saturated, long-chain fatty acid ketogenic diet negatively impacts visual and motor-sensory function in a pre-clinical model of multiple sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Erin N.","family":"Capper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin W.","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy H.","family":"Kardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver W.","family":"Gramlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclersosis: clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000631","article-title":"Multiple sclerosis: eyes on the future","volume":"38","author":"Costello","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"B5","first-page":"269","article-title":"Some newer imidazolones and their anti-inflammatory activity","volume":"42","author":"Pande","year":"1987","journal-title":"Pharmazie"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000768","article-title":"Optic neuritis","volume":"25","author":"Bennett","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10352-1","article-title":"The changing landscape of optic neuritis: a narrative review","volume":"269","author":"De Lott","year":"2022","journal-title":"J Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8376","article-title":"Retinal pathway origins of the pattern electroretinogram (PERG)","volume":"52","author":"Luo","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64032-1.00034-5","article-title":"Visually evoked potentials","volume":"160","author":"Creel","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD015443","DOI":"10.1002\/14651858.CD015443.pub2","article-title":"Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis","volume":"9","author":"Ridley","year":"2024","journal-title":"The Cochrane database of systematic reviews"},{"key":"B12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener Dis Manage"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.03.005","article-title":"Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment","volume":"176","author":"Ouallet","year":"2020","journal-title":"Rev Neurol (Paris)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10100758","article-title":"Anti-CD20 agents for multiple sclerosis: spotlight on ocrelizumab and ofatumumab","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01224-9","article-title":"Monoclonal antibodies in the treatment of relapsing multiple sclerosis: an overview with emphasis on pregnancy, vaccination, and risk management","volume":"19","author":"Krajnc","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182872855","article-title":"Disability in multiple sclerosis: a reference for patients and clinicians","volume":"80","author":"Kister","year":"2013","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"10371","DOI":"10.1038\/s41598-019-46251-3","article-title":"In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"9","author":"Vabanesi","year":"2019","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-018-0236-z","article-title":"The role of diet in multiple sclerosis: mechanistic connections and current evidence","volume":"7","author":"Katz Sand","year":"2018","journal-title":"Curr Nutr Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e565","DOI":"10.1212\/NXI.0000000000000565","article-title":"Pilot study of a ketogenic diet in relapsing-remitting MS","volume":"6","author":"Brenton","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/nu14235003","article-title":"The role of ketogenic diet in the treatment of neurological diseases","volume":"14","author":"Dynka","year":"2022","journal-title":"Nutrients"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122384","article-title":"Ketogenic and modified mediterranean diet as a tool to counteract neuroinflammation in multiple sclerosis: nutritional suggestions","volume":"14","author":"Di Majo","year":"2022","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1556\/1886.2023.00020","article-title":"The impact of ketogenic diet on the onset and progression of multiple sclerosis","volume":"13","author":"Brockhoff","year":"2023","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1039\/D3FO00122A","article-title":"Ketogenic diet attenuates neuroinflammation and induces conversion of M1 microglia to M2 in an EAE model of multiple sclerosis by regulating the NF-kappaB\/NLRP3 pathway and inhibiting HDAC3 and P2X7R activation","volume":"14","author":"Sun","year":"2023","journal-title":"Food Funct"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2300602","DOI":"10.1002\/mnfr.202300602","article-title":"A high MCT-based ketogenic diet suppresses th1 and th17 responses to ameliorate experimental autoimmune encephalomyelitis in mice by inhibiting GSDMD and JAK2-STAT3\/4 pathways","volume":"68","author":"Zhang","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1113954","article-title":"Dietary protection against the visual and motor deficits induced by experimental autoimmune encephalomyelitis","volume":"14","author":"Zyla-Jackson","year":"2023","journal-title":"Front Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e35476","DOI":"10.1371\/journal.pone.0035476","article-title":"Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis","volume":"7","author":"Kim","year":"2012","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.05.009","article-title":"A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.04.005","article-title":"Fatty acids prevent hypoxia-inducible factor-1\u03b1 Signaling through decrease succinate in diabetes","volume":"3","author":"Dodd","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271118","article-title":"Acriflavine, a HIF-1 inhibitor, preserves vision in an experimental autoimmune encephalomyelitis model of optic neuritis","volume":"14","author":"Anders","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"104424","DOI":"10.1016\/j.msard.2022.104424","article-title":"Mobility and balance rehabilitation in multiple sclerosis: A systematic review and dose-response meta-analysis","volume":"69","author":"Corrini","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.9.8.16","article-title":"Systemic mesenchymal stem cell treatment mitigates structural and functional retinal ganglion cell degeneration in a mouse model of multiple sclerosis","volume":"9","author":"Gramlich","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101437","article-title":"Targeting cholesterol homeostasis improves recovery in experimental optic neuritis","volume":"12","author":"Godwin","year":"2022","journal-title":"Biomolecules"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12714","article-title":"Dynamics, alterations, and consequences of minimally invasive intraocular pressure elevation in rats","volume":"55","author":"Gramlich","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8034","DOI":"10.1038\/s41598-020-64898-1","article-title":"AxoNet: A deep learning-based tool to count retinal ganglion cell axons","volume":"10","author":"Ritch","year":"2020","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41592-018-0261-2","article-title":"U-Net: deep learning for cell counting, detection, and morphometry","volume":"16","author":"Falk","year":"2019","journal-title":"Nat Methods"},{"key":"B36","article-title":"A review of ketogenic diet and lifestyle","volume":"119","author":"McGaugh","year":"2022","journal-title":"Mo Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13063-019-3928-9","article-title":"Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study","volume":"21","author":"Bahr","year":"2020","journal-title":"Trials"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3791\/51275","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","volume":"86","author":"Bittner","year":"2014","journal-title":"J Vis Exp"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020352","article-title":"Review of two popular eating plans within the multiple sclerosis community: low saturated fat and modified paleolithic","volume":"11","author":"Wahls","year":"2019","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","first-page":"293S","DOI":"10.3945\/an.114.006940","article-title":"The science of fatty acids and inflammation","volume":"6","author":"Fritsche","year":"2015","journal-title":"Adv Nutr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","article-title":"The role of short-chain fatty acids in health and disease","volume":"121","author":"Tan","year":"2014","journal-title":"Adv Immunol"},{"key":"B42","article-title":"The use of medium-chain triglycerides in gastrointestinal disorders","volume":"160","author":"Shah","year":"2017","journal-title":"Pract Gastroenterol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e3283620616","article-title":"Long chain fatty acids and gene expression in inflammation and immunity","volume":"16","author":"Calder","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B44","volume-title":"Ketogenic diet","author":"Masood","year":"2025"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16768","article-title":"Relationship between pattern electroretinogram, frequency-domain OCT, and automated perimetry in chronic papilledema from pseudotumor cerebri syndrome","volume":"56","author":"Afonso","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1587760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:14:16Z","timestamp":1747887256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1587760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2025.1587760"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1587760","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"article-number":"1587760"}}